North America Oral Care Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Toothpastes, Toothbrushes and Accessories, Mouthwashes/Rinses, Denture Products, Dental Prosthesis Cleaning Solutions, Dental Accessories/Ancillaries, and

North America Oral Care Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Toothpastes, Toothbrushes and Accessories, Mouthwashes/Rinses, Denture Products, Dental Prosthesis Cleaning Solutions, Dental Accessories/Ancillaries, and Other Dental Products), Distribution Channel (Supermarkets/Hypermarkets, Convenience Stores, Pharmacies and Drug Stores, Online Retail Stores, and Other Distribution Channels)

The North America oral care market is expected to grow from US$ 10,566.3 million in 2021 to US$ 13,492.0 million by 2028; it is estimated to grow at a CAGR of 3.6% from 2021 to 2028. Proper oral and dental hygiene is essential for human well-being, as it helps prevent several oral diseases. A few of the oral and dental care issues that affect people include bad breath, tooth decay, gum diseases, periodontal diseases, trench mouth, dental caries, and malocclusion. Alcohol consumption, tobacco use, human papillomavirus (HPV), and sun exposure, especially to the lips, are a few risk factors associated with oropharyngeal and oral cancers. Administrating the HPV vaccine and scheduling regular dental hygiene visits can reduce the risk of cancer. Many private and government organizations organize surveys and programs globally to raise awareness about oral hygiene. Bright Futures—a national health promotion and prevention initiative led by the American Academy of Pediatrics (AAP)—provides “Periodicity Schedule,” the Preventive Pediatric Health Care recommendations, to offer a schedule of assessments and screenings. This schedule helps maintain oral hygiene in each visiting well-child from their infancy through adolescence. Thus, the rise in such initiatives with the growing awareness regarding oral care is fueling the North America oral care products market growth.

Based on product, the oral care market is segmented into toothpastes, denture products, toothbrushes and accessories, mouthwashes/rinses, dental accessories/ancillaries, dental prosthesis cleaning solutions, and other dental products. In 2021, the toothpastes segment accounted for the highest share of the market. However, the toothbrushes and accessories segment is estimated to register the highest CAGR during the forecast period. Increased use of toothpaste among people of all income groups can be attributed to the growth of this segment. The availability of different flavors of toothpaste, such as mint, lime, and strawberry, with various forms of toothpaste, such as gels, pastes, and powder, also boosts demand. Furthermore, the increasing prevalence of oral conditions and growing disposable incomes are anticipated to drive the growth of cosmetics segment.

The COVID-19 pandemic could lead to potential disruptions in the distribution channel during the lockdown, resulting in the imposition of restrictions on travel in North America to and reduce the spread of SARS-CoV-2. Social distancing protocols and quarantine measures led to a shift in consumer purchasing patterns from in-store to online portals, affecting the sales of oral care/oral hygiene products. Major players in the market have continued their production activities during this period. Colgate-Palmolive Company, an American multinational consumer products company, suggested that its oral care products may play a role in temporarily reducing the amount of SARS-CoV-2 in the mouth. Laboratory tests found that specific toothpaste, mouthwashes, and mouth spray neutralized SARS-CoV-2 by more than 99%.

The overall North America oral care market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the North America oral care market with respect to all the market segments. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights into the topic. Participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the North America oral care market. Companies adopt a few strategies, such as mergers, acquisitions, and market initiatives, which promote market growth. Koninklijke Philips N.V.; Colgate-Palmolive Company; Procter & Gamble; GlaxoSmithKline plc.; Unilever; Johnson and Johnson Services, Inc.; Perrigo Company plc; Lion Corporation; Sunstar Suisse S.A.; and Church & Dwight, Inc. are among the key players operating in the market in this region.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America oral care market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America oral care market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.


1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Next-generation Antibody Market - By Therapeutic Area
1.3.2 North America Next-generation Antibody Market - By Technology
1.3.3 North America Next-generation Antibody Market - By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Next-generation Antibody Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.3 Experts Opinion
5. Next-generation Antibody Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Cancer
5.1.2 Growing Demand for Next-Generation Antibody Therapeutics
5.2 Market Restraints
5.2.1 Complications Associated with Manufacturing and Approvals
5.3 Future Trends
5.3.1 Developments in Next-Generation Antibodies
5.4 Impact Analysis
6. Next-generation Antibody Market-North America Analysis
6.1 North America Next-generation Antibody Market Revenue Forecast and Analysis
7. North America Next-generation Antibody Market Revenue and Forecasts To 2028- by Therapeutic Area
7.1 Overview
7.2 North America Next-generation Antibody Market, By Therapeutic Area, 2021 & 2028 (%)
7.3 Oncology
7.3.1 Overview
7.3.2 Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)
7.4 Autoimmune or Inflammatory
7.4.1 Overview
7.4.2 Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)
8. Next-generation Antibody Market Revenue and Forecasts To 2028 - Technology
8.1 Overview
8.2 Global Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)
8.3 Antibody-drug conjugates
8.3.1 Overview
8.3.2 Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)
8.4 Bispecific antibodies
8.4.1 Overview
8.4.2 Bispecific antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)
8.5 Fc engineered antibodies
8.5.1 Overview
8.5.2 Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)
8.6 Antibody fragments and antibody-like proteins
8.6.1 Overview
8.6.2 Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)
8.7 Biosimilar antibody products
8.7.1 Overview
8.7.2 Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)
9. North America Next-generation Antibody Market Revenue and Forecasts to 2028 - Country Analysis
9.1 North America: Next-generation Antibody Market
9.1.1 Overview
9.1.2 North America: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Next-generation Antibody Market, by Therapeutic Area, 2019-2028 (US$ Million)
9.1.4 North America: Next-generation Antibody Market, by Technology, 2019-2028 (US$ Million)
9.1.5 North America: Next-generation Antibody Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Overview
9.1.5.1.2 US: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.3 US: Next-generation Antibody Market, by Therapeutic Area, 2019-2028 (US$ Million)
9.1.5.1.4 US: Next-generation Antibody Market, by Technology, 2019-2028 (US$ Million)
9.1.5.2 Canada: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Overview
9.1.5.2.2 Canada: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Canada: Next-generation Antibody Market, by Therapeutic Area, 2019-2028 (US$ Million)
9.1.5.2.4 Canada: Next-generation Antibody Market, by Technology, 2019-2028 (US$ Million)
9.1.5.3 Mexico: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Overview
9.1.5.3.2 Mexico: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 Mexico: Next-generation Antibody Market, by Therapeutic Area, 2019-2028 (US$ Million)
9.1.5.3.4 Mexico: Next-generation Antibody Market, by Technology, 2019-2028 (US$ Million)
10. Impact Of COVID-19 Pandemic on Next-generation Antibody Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Next-generation Antibody Market-Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 F. HOFFMANN-LA ROCHE LTD.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Kyowa Kirin Co., Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Seagen Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 ImmunoGen, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Takeda Pharmaceutical Company Limited
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Amgen Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Pfizer Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Catalent Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 AstraZeneca
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Xencor
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
list of Tables
Table 1. New Cancer Cases Registered Worldwide, 2020
Table 2. North America Next-generation Antibody Market, by Therapeutic Area - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Next-generation Antibody Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 4. US Next-generation Antibody Market, by Therapeutic Area - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Next-generation Antibody Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Next-generation Antibody Market, by Therapeutic Area - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Next-generation Antibody Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Next-generation Antibody Market, by Therapeutic Area - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Next-generation Antibody Market, by Technology- Revenue and Forecast to 2028 (US$ Million)
Table 10. Organic Developments in the Next-generation Antibody Market
Table 11. Inorganic Developments in the Next-generation Antibody Market
Table 12. Glossary of Terms
List of Figures
Figure 1. Next-generation Antibody Market Segmentation
Figure 2. Next-generation Antibody Market, By Country
Figure 3. North America Next-generation Antibody Market Overview
Figure 4. Oncology Segment Held Largest Share of Therapeutic Area Segment in Next-generation Antibody Market
Figure 5. North America Next-generation Antibody Market- Leading Country Markets (US$ Million)
Figure 6. North America: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Next-Generation Antibody Market Impact Analysis of Driver and Restraints
Figure 9. North America Next-generation Antibody Market- Revenue Forecast and Analysis - 2021 - 2028
Figure 10. North America Next-generation Antibody Market, by Therapeutic Area, 2021 & 2028 (%)
Figure 11. Oncology: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Autoimmune or Inflammatory: Next-generation Antibody Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Global Next-generation Antibody Market Share by Segment - 2021 & 2028 (%)
Figure 14. Antibody-drug conjugates: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)
Figure 15. Bispecific antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)
Figure 16. Fc engineered antibodies: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)
Figure 17. Antibody fragments and antibody-like proteins: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)
Figure 18. Biosimilar antibody products: Next-generation Antibody Market Revenue and Forecasts To 2028 (US$ Million)
Figure 19. North America: Next-generation Antibody Market, by Key Country - Revenue (2021) (US$ Million)
Figure 20. North America Next-generation Antibody Market Revenue and Forecast to 2028 (US$ Million)
Figure 21. North America: Next-generation Antibody Market, by Country, 2021 & 2028 (%)
Figure 22. US: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Canada: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
Figure 24. Mexico: Next-generation Antibody Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Impact of COVID-19 Pandemic in North American Country Markets

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings